Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 5/2022

07-08-2021 | Alzheimer's Disease | Original Paper

Imminent cognitive decline in normal elderly individuals is associated with hippocampal hyperconnectivity in the variant neural correlates of episodic memory

Authors: Hao Shu, Gang Chen, B. Douglas Ward, Guangyu Chen, Zan Wang, Duan Liu, Fan Su, Lihua Gu, Zhan Xu, Shi-Jiang Li, Zhijun Zhang, for the Alzheimer’s Disease Neuroimaging Initiative

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 5/2022

Login to get access

Abstract

The secondary prevention trials of Alzheimer’s disease (AD) require an enrichment strategy to recruit individuals with imminent cognitive decline at the preclinical stage. Previously, we demonstrated a variant neural correlates of episodic memory (EM) function in apolipoprotein E (APOE) ε4 carriers. Herein, we investigated whether this variation was associated with longitudinal EM performance. This 3-year longitudinal study included 88 normal elderly subjects with EM assessment and resting-state functional MRI data at baseline; 48 subjects (27 ε3 homozygotes and 21 ε4 carriers) underwent follow-up EM assessment. In the identified EM neural correlates, multivariable regression models examined the association between hippocampal functional connectivity (HFC) and longitudinal EM change. Independent validation was performed using the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. At baseline, the EM neural correlates were characterized in the Papez circuit regions in the ε3 homozygotes, but in the sensorimotor cortex and cuneus in the ε4 carriers. Longitudinally, the ε4 carriers exhibited a negative association of the baseline HFC strength in the EM neural correlates with annual rate of EM change (R2 = 0.25, p = 0.05). This association also showed a trend in the ADNI dataset (R2 = 0.42, p = 0.06). These results indicate that hippocampal hyperconnectivity in the variant EM neural correlates is associated with imminent EM decline in ε4 carriers, which may serve as a promising enrichment strategy for secondary prevention trials of AD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207–216PubMedPubMedCentralCrossRef Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207–216PubMedPubMedCentralCrossRef
2.
go back to reference Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292PubMedPubMedCentralCrossRef Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292PubMedPubMedCentralCrossRef
3.
go back to reference Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O'Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CR, Jr., Proceedings of the Meeting of the International Working G, the American Alzheimer's Association on "The Preclinical State of AD, July, Washington Dc USA (2016) Preclinical alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement 12:292–323 Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O'Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CR, Jr., Proceedings of the Meeting of the International Working G, the American Alzheimer's Association on "The Preclinical State of AD, July, Washington Dc USA (2016) Preclinical alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement 12:292–323
4.
go back to reference Soldan A, Pettigrew C, Cai Q, Wang MC, Moghekar AR, O’Brien RJ, Selnes OA, Albert MS, Team BR (2016) Hypothetical preclinical Alzheimer disease groups and longitudinal cognitive change. JAMA Neurol 73:698–705PubMedPubMedCentralCrossRef Soldan A, Pettigrew C, Cai Q, Wang MC, Moghekar AR, O’Brien RJ, Selnes OA, Albert MS, Team BR (2016) Hypothetical preclinical Alzheimer disease groups and longitudinal cognitive change. JAMA Neurol 73:698–705PubMedPubMedCentralCrossRef
5.
go back to reference Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen CL, Benzinger TL, Mintun MA, Holtzman DM, Morris JC (2013) Amyloid imaging and csf biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology 80:1784–1791PubMedPubMedCentralCrossRef Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen CL, Benzinger TL, Mintun MA, Holtzman DM, Morris JC (2013) Amyloid imaging and csf biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology 80:1784–1791PubMedPubMedCentralCrossRef
7.
go back to reference Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci 106:7209–7214PubMedPubMedCentralCrossRef Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci 106:7209–7214PubMedPubMedCentralCrossRef
8.
go back to reference Sperling RA, Laviolette PS, O’Keefe K, O’Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63:178–188PubMedPubMedCentralCrossRef Sperling RA, Laviolette PS, O’Keefe K, O’Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63:178–188PubMedPubMedCentralCrossRef
9.
go back to reference Chen G, Shu H, Chen G, Ward BD, Antuono PG, Zhang Z, Li SJ, Alzheimer’s Disease Neuroimaging I (2016) Staging Alzheimer’s disease risk by sequencing brain function and structure, cerebrospinal fluid, and cognition biomarkers. J Alzheimers Dis 54:983–993PubMedPubMedCentralCrossRef Chen G, Shu H, Chen G, Ward BD, Antuono PG, Zhang Z, Li SJ, Alzheimer’s Disease Neuroimaging I (2016) Staging Alzheimer’s disease risk by sequencing brain function and structure, cerebrospinal fluid, and cognition biomarkers. J Alzheimers Dis 54:983–993PubMedPubMedCentralCrossRef
10.
go back to reference Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, Konnerth A (2012) Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci 109:8740–8745PubMedPubMedCentralCrossRef Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, Konnerth A (2012) Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci 109:8740–8745PubMedPubMedCentralCrossRef
11.
go back to reference Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, Lee JM, Holtzman DM (2011) Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat Neurosci 14:750–756PubMedPubMedCentralCrossRef Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, Lee JM, Holtzman DM (2011) Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat Neurosci 14:750–756PubMedPubMedCentralCrossRef
12.
go back to reference Yamamoto K, Tanei ZI, Hashimoto T, Wakabayashi T, Okuno H, Naka Y, Yizhar O, Fenno LE, Fukayama M, Bito H, Cirrito JR, Holtzman DM, Deisseroth K, Iwatsubo T (2015) Chronic optogenetic activation augments abeta pathology in a mouse model of Alzheimer disease. Cell Rep 11:859–865PubMedCrossRef Yamamoto K, Tanei ZI, Hashimoto T, Wakabayashi T, Okuno H, Naka Y, Yizhar O, Fenno LE, Fukayama M, Bito H, Cirrito JR, Holtzman DM, Deisseroth K, Iwatsubo T (2015) Chronic optogenetic activation augments abeta pathology in a mouse model of Alzheimer disease. Cell Rep 11:859–865PubMedCrossRef
13.
go back to reference Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron 55:697–711PubMedPubMedCentralCrossRef Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron 55:697–711PubMedPubMedCentralCrossRef
14.
go back to reference Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, Garaschuk O (2008) Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease. Science 321:1686–1689PubMedCrossRef Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, Garaschuk O (2008) Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease. Science 321:1686–1689PubMedCrossRef
15.
go back to reference Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, Devidze N, Ho K, Yu GQ, Palop JJ, Mucke L (2012) Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model. Proc Natl Acad Sci 109:E2895-2903PubMedPubMedCentral Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, Devidze N, Ho K, Yu GQ, Palop JJ, Mucke L (2012) Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model. Proc Natl Acad Sci 109:E2895-2903PubMedPubMedCentral
16.
go back to reference Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, Yassa MA, Bassett SS, Shelton AL, Gallagher M (2012) Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 74:467–474PubMedPubMedCentralCrossRef Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, Yassa MA, Bassett SS, Shelton AL, Gallagher M (2012) Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 74:467–474PubMedPubMedCentralCrossRef
17.
go back to reference Bakker A, Albert MS, Krauss G, Speck CL, Gallagher M (2015) Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by FMRI and memory task performance. Neuroimage Clin 7:688–698PubMedPubMedCentralCrossRef Bakker A, Albert MS, Krauss G, Speck CL, Gallagher M (2015) Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by FMRI and memory task performance. Neuroimage Clin 7:688–698PubMedPubMedCentralCrossRef
18.
go back to reference Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer’s disease. Lancet 377:1019–1031PubMedCrossRef Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer’s disease. Lancet 377:1019–1031PubMedCrossRef
19.
go back to reference Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, DeKosky ST, Caselli RJ (2009) Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer’s disease. Proc Natl Acad Sci 106:6820–6825PubMedPubMedCentralCrossRef Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, DeKosky ST, Caselli RJ (2009) Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer’s disease. Proc Natl Acad Sci 106:6820–6825PubMedPubMedCentralCrossRef
20.
go back to reference Trachtenberg AJ, Filippini N, Mackay CE (2012) The effects of APOE-epsilon4 on the BOLD response. Neurobiol Aging 33:323–334PubMedCrossRef Trachtenberg AJ, Filippini N, Mackay CE (2012) The effects of APOE-epsilon4 on the BOLD response. Neurobiol Aging 33:323–334PubMedCrossRef
21.
go back to reference Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM (2009) Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 361:255–263PubMedPubMedCentralCrossRef Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM (2009) Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 361:255–263PubMedPubMedCentralCrossRef
22.
go back to reference Shu H, Shi Y, Chen G, Wang Z, Liu D, Yue C, Ward BD, Li W, Xu Z, Chen G, Guo QH, Xu J, Li SJ, Zhang Z (2019) Distinct neural correlates of episodic memory among apolipoprotein e alleles in cognitively normal elderly. Brain Imaging Behav 13:255–269PubMedPubMedCentralCrossRef Shu H, Shi Y, Chen G, Wang Z, Liu D, Yue C, Ward BD, Li W, Xu Z, Chen G, Guo QH, Xu J, Li SJ, Zhang Z (2019) Distinct neural correlates of episodic memory among apolipoprotein e alleles in cognitively normal elderly. Brain Imaging Behav 13:255–269PubMedPubMedCentralCrossRef
23.
go back to reference Guo Q, Zhao Q, Chen M, Ding D, Hong Z (2009) A comparison study of mild cognitive impairment with 3 memory tests among Chinese individuals. Alzheimer Dis Assoc Disord 23:253–259PubMedCrossRef Guo Q, Zhao Q, Chen M, Ding D, Hong Z (2009) A comparison study of mild cognitive impairment with 3 memory tests among Chinese individuals. Alzheimer Dis Assoc Disord 23:253–259PubMedCrossRef
24.
go back to reference Shu H, Shi Y, Chen G, Wang Z, Liu D, Yue C, Ward BD, Li W, Xu Z, Chen G, Guo Q, Xu J, Li SJ, Zhang Z (2016) Opposite neural trajectories of apolipoprotein e 4 and 2 alleles with aging associated with different risks of Alzheimer’s disease. Cereb Cortex 26:1421–1429PubMedCrossRef Shu H, Shi Y, Chen G, Wang Z, Liu D, Yue C, Ward BD, Li W, Xu Z, Chen G, Guo Q, Xu J, Li SJ, Zhang Z (2016) Opposite neural trajectories of apolipoprotein e 4 and 2 alleles with aging associated with different risks of Alzheimer’s disease. Cereb Cortex 26:1421–1429PubMedCrossRef
25.
go back to reference Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of FMRI data sets. Neuroimage 19:1233–1239PubMedCrossRef Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of FMRI data sets. Neuroimage 19:1233–1239PubMedCrossRef
26.
go back to reference Luo X, Qiu T, Jia Y, Huang P, Xu X, Yu X, Shen Z, Jiaerken Y, Guan X, Zhou J, Zhang M, Adni, (2017) Intrinsic functional connectivity alterations in cognitively intact elderly apoe epsilon4 carriers measured by eigenvector centrality mapping are related to cognition and csf biomarkers: a preliminary study. Brain Imaging Behav 11:1290–1301PubMedCrossRef Luo X, Qiu T, Jia Y, Huang P, Xu X, Yu X, Shen Z, Jiaerken Y, Guan X, Zhou J, Zhang M, Adni, (2017) Intrinsic functional connectivity alterations in cognitively intact elderly apoe epsilon4 carriers measured by eigenvector centrality mapping are related to cognition and csf biomarkers: a preliminary study. Brain Imaging Behav 11:1290–1301PubMedCrossRef
27.
go back to reference McKenna F, Koo BB, Killiany R, Alzheimer’s Disease Neuroimaging I (2016) Comparison of ApoE-related brain connectivity differences in early MCI and normal aging populations: an FMRI study. Brain Imaging Behav 10:970–983PubMedCrossRef McKenna F, Koo BB, Killiany R, Alzheimer’s Disease Neuroimaging I (2016) Comparison of ApoE-related brain connectivity differences in early MCI and normal aging populations: an FMRI study. Brain Imaging Behav 10:970–983PubMedCrossRef
28.
go back to reference Goldberg TE, Harvey PD, Wesnes KA, Snyder PJ, Schneider LS (2015) Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer’s disease randomized controlled trials. Alzheimers Dement 1:103–111 Goldberg TE, Harvey PD, Wesnes KA, Snyder PJ, Schneider LS (2015) Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer’s disease randomized controlled trials. Alzheimers Dement 1:103–111
29.
go back to reference Hyman BT, Gomez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, Wallace R (1996) Apolipoprotein e and cognitive change in an elderly population. Ann Neurol 40:55–66PubMedCrossRef Hyman BT, Gomez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, Wallace R (1996) Apolipoprotein e and cognitive change in an elderly population. Ann Neurol 40:55–66PubMedCrossRef
30.
go back to reference Yu L, Boyle PA, Leurgans S, Schneider JA, Bennett DA (2014) Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging 35:819–826PubMedCrossRef Yu L, Boyle PA, Leurgans S, Schneider JA, Bennett DA (2014) Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging 35:819–826PubMedCrossRef
31.
go back to reference Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RA, Alzheimer’s Disease Neuroimaging I, Australian Imaging B, Lifestyle Flagship Study of A, Harvard Aging Brain S (2014) Amyloid and APOE epsilon4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology 82:1760–1767PubMedPubMedCentralCrossRef Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RA, Alzheimer’s Disease Neuroimaging I, Australian Imaging B, Lifestyle Flagship Study of A, Harvard Aging Brain S (2014) Amyloid and APOE epsilon4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology 82:1760–1767PubMedPubMedCentralCrossRef
33.
34.
go back to reference O’Brien JL, O’Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, Sperling RA (2010) Longitudinal FMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology 74:1969–1976PubMedPubMedCentralCrossRef O’Brien JL, O’Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, Sperling RA (2010) Longitudinal FMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology 74:1969–1976PubMedPubMedCentralCrossRef
36.
go back to reference Kukolja J, Thiel CM, Eggermann T, Zerres K, Fink GR (2010) Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers. Neuroscience 168:487–497PubMedCrossRef Kukolja J, Thiel CM, Eggermann T, Zerres K, Fink GR (2010) Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers. Neuroscience 168:487–497PubMedCrossRef
37.
go back to reference Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, Bondi MW (2005) Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol 62:1881–1888PubMedCrossRef Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, Bondi MW (2005) Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol 62:1881–1888PubMedCrossRef
38.
go back to reference Bondi MW, Houston WS, Eyler LT, Brown GG (2005) FMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64:501–508PubMedCrossRef Bondi MW, Houston WS, Eyler LT, Brown GG (2005) FMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64:501–508PubMedCrossRef
39.
go back to reference Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG, Corey-Bloom J, Salmon DP, Thal LJ, Bondi MW (2007) Verbal paired-associate learning by APOE genotype in non-demented older adults: FMRI evidence of a right hemispheric compensatory response. Neurobiol Aging 28:238–247PubMedCrossRef Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG, Corey-Bloom J, Salmon DP, Thal LJ, Bondi MW (2007) Verbal paired-associate learning by APOE genotype in non-demented older adults: FMRI evidence of a right hemispheric compensatory response. Neurobiol Aging 28:238–247PubMedCrossRef
40.
go back to reference Tuminello ER, Han SD (2011) The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations. Int J Alzheimers Dis 2011:726197PubMedPubMedCentral Tuminello ER, Han SD (2011) The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations. Int J Alzheimers Dis 2011:726197PubMedPubMedCentral
43.
go back to reference Nadkarni NK, Perera S, Snitz BE, Mathis CA, Price J, Williamson JD, DeKosky ST, Klunk WE, Lopez OL (2017) Association of brain amyloid-beta with slow gait in elderly individuals without dementia: influence of cognition and apolipoprotein e epsilon4 genotype. JAMA Neurol 74:82–90PubMedPubMedCentralCrossRef Nadkarni NK, Perera S, Snitz BE, Mathis CA, Price J, Williamson JD, DeKosky ST, Klunk WE, Lopez OL (2017) Association of brain amyloid-beta with slow gait in elderly individuals without dementia: influence of cognition and apolipoprotein e epsilon4 genotype. JAMA Neurol 74:82–90PubMedPubMedCentralCrossRef
44.
go back to reference Verghese J, Wang C, Lipton RB, Holtzer R, Xue X (2007) Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry 78:929–935PubMedPubMedCentralCrossRef Verghese J, Wang C, Lipton RB, Holtzer R, Xue X (2007) Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry 78:929–935PubMedPubMedCentralCrossRef
45.
go back to reference Marquis S, Moore MM, Howieson DB, Sexton G, Payami H, Kaye JA, Camicioli R (2002) Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 59:601–606PubMedCrossRef Marquis S, Moore MM, Howieson DB, Sexton G, Payami H, Kaye JA, Camicioli R (2002) Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 59:601–606PubMedCrossRef
47.
go back to reference Grill JD, Monsell SE (2014) Choosing Alzheimer’s disease prevention clinical trial populations. Neurobiol Aging 35:466–471PubMedCrossRef Grill JD, Monsell SE (2014) Choosing Alzheimer’s disease prevention clinical trial populations. Neurobiol Aging 35:466–471PubMedCrossRef
48.
go back to reference Patriat R, Molloy EK, Meier TB, Kirk GR, Nair VA, Meyerand ME, Prabhakaran V, Birn RM (2013) The effect of resting condition on resting-state FMRI reliability and consistency: a comparison between resting with eyes open, closed, and fixated. Neuroimage 78:463–473PubMedCrossRef Patriat R, Molloy EK, Meier TB, Kirk GR, Nair VA, Meyerand ME, Prabhakaran V, Birn RM (2013) The effect of resting condition on resting-state FMRI reliability and consistency: a comparison between resting with eyes open, closed, and fixated. Neuroimage 78:463–473PubMedCrossRef
Metadata
Title
Imminent cognitive decline in normal elderly individuals is associated with hippocampal hyperconnectivity in the variant neural correlates of episodic memory
Authors
Hao Shu
Gang Chen
B. Douglas Ward
Guangyu Chen
Zan Wang
Duan Liu
Fan Su
Lihua Gu
Zhan Xu
Shi-Jiang Li
Zhijun Zhang
for the Alzheimer’s Disease Neuroimaging Initiative
Publication date
07-08-2021
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 5/2022
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-021-01310-7

Other articles of this Issue 5/2022

European Archives of Psychiatry and Clinical Neuroscience 5/2022 Go to the issue